Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2023-01-23 08:16 am |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | MARGOLIN YAEL Director |
0 | $0 | 1,920,000 (Direct) |
View |
Ownership(A) |
2023-01-23 08:10 am |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | Laster Morris C Director |
0 | $0 | 1,920,000 (Direct) |
View |
Ownership(A) |
2023-01-23 08:04 am |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | Lowell George Director |
0 | $0 | 2,274,880 (Direct) |
View |
Ownership(A) |
2023-01-23 08:00 am |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | Rotman Avner Director |
0 | $0 | 2,058,780 (Direct) |
View |
Ownership |
2023-01-05 12:48 pm |
N/A 2029-11-19 |
BiondVax Pharmaceuticals Ltd. | BVXV | Moed Samuel J Director |
0 | $0 | 4,000,000 (Direct) |
View |
Ownership |
2023-01-03 3:46 pm |
N/A 2031-12-27 |
BiondVax Pharmaceuticals Ltd. | BVXV | Green Jay Director |
0 | $0 | 1,200,000 (Direct) |
View |
Ownership |
2023-01-03 3:18 pm |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | MARGOLIN YAEL Director |
0 | $0 | 1,920,000 (Direct) |
View |
Ownership |
2023-01-03 3:16 pm |
2024-09-23 2031-09-21 |
BiondVax Pharmaceuticals Ltd. | BVXV | Ben-Or Uri Chief Financial Officer |
0 | $0 | 880,000 (Direct) |
View |
Ownership |
2023-01-03 3:14 pm |
2024-09-23 2031-09-21 |
BiondVax Pharmaceuticals Ltd. | BVXV | Ben-Yedidia Tamar Chief Scientist |
0 | $0 | 3,140,000 (Direct) |
View |
Ownership |
2023-01-03 3:12 pm |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | Laster Morris C Director |
0 | $0 | 1,920,000 (Direct) |
View |
Ownership |
2023-01-03 3:11 pm |
N/A 2029-05-25 |
BiondVax Pharmaceuticals Ltd. | BVXV | GERMAIN MARK Chairman |
0 | $0 | 11,628,400 (Direct) |
View |
Ownership |
2023-01-03 3:09 pm |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | Lowell George Director |
0 | $0 | 2,274,880 (Direct) |
View |
Ownership |
2023-01-03 3:07 pm |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | Rotman Avner Director |
0 | $0 | 2,058,780 (Direct) |
View |
Ownership |
2023-01-03 3:05 pm |
2031-03-02 N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | Reichman Amir Chief Executive Officer |
0 | $0 | 24,000,000 (Direct) |
View |
Ownership |
2023-01-03 3:04 pm |
N/A N/A |
BiondVax Pharmaceuticals Ltd. | BVXV | Raviv Adi Director |
0 | $0 | 1,920,000 (Direct) |
View |
Ownership |
2023-01-03 3:02 pm |
2024-10-18 2031-10-16 |
BiondVax Pharmaceuticals Ltd. | BVXV | Mark Elad Chief Operating Officer |
0 | $0 | 1,772,000 (Direct) |
View |